Quest Diagnostics (NYSE:DGX) Hits New 12-Month Peak After Impressive Earnings Report

2 min read | January 30, 2025 10:28 PM PST | By Team Kalkine Media

Quest Diagnostics (NYSE:DGX) Hits New 12-Month Peak After Impressive Earnings Report

Financial Performance

Quest Diagnostics exceeded expectations by reporting an earnings per share of $2.23 for the last quarter, surpassing the consensus estimate of $2.19. This performance highlights the company's strong operational efficiency, as evidenced by a return on equity of 15.25% and a net margin of 8.82%. Moreover, Quest Diagnostics has also increased its quarterly dividend to $0.80, indicating both financial stability and a commitment to returning value to shareholders.

Insider and Institutional Activity

Recent insider transactions include a significant stock sale by CEO Michael J. Deppe. Institutional investors such as Versant Capital Management Inc, First Financial Corp IN, and others have substantially increased their stakes in Quest Diagnostics. Currently, 88.06% of the company's stock is owned by institutional entities, underscoring widespread investor confidence.

Company Growth and Outlook

Quest Diagnostics maintains a healthy debt-to-equity ratio of 0.83 and operates with favorable liquidity ratios, suggesting overall financial health. With an 18.30 billion-dollar market capitalization and strategic growth initiatives, the company remains well-positioned for sustained future performance.

Conclusion

Quest Diagnostics' recent achievements in hitting a new stock high and surpassing earnings expectations underscore its strategic growth and strong market presence. As institutional investors continue to place their confidence in the company, Quest Diagnostics remains a significant player in the medical research sector with promising prospects.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.